Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptors (CAR)-T in Relapsed/Refractory Acute Lymphoblastic Leukemia

作者：Gang Heng, Jiankun Jia, Shiqi Li, Gang Fu, Meiling Wang, Dabing Qin, Yunyan Li, Pei Li, Zhouxing Xiong, Xiaobo Tian, Rui Zhang, Jiasi Zhang, Shali Xiang, Qian Wen, Jia Wan, Wei Zhu, Pei Zhang, Yingzi Zhang, Xi Peng, Linling Wang, Ping Wang, Zhihao Wei, Run Chen Chen, Guiqin Wang, Xue Chen, Chengcheng Zhang, Yanni Sun, Wenxu Zhao, Yahan Fan, Zhi Hong Yang, Jieping Chen, Cheng Qian · 发表于：SSRN Electronic Journal · 年份：2018 · DOI：10.2139/ssrn.3307655 · 被引用次数：2 · 研究领域：CAR-T cell therapy research、Acute Lymphoblastic Leukemia research、Biosimilars and Bioanalytical Methods